Anemia Management in CKD Patients in the Era of New US Food and Drug Administration Recommendations on the Use of Erythropoiesis-Stimulating Agents

被引:0
作者
Kaufman, James S. [1 ]
机构
[1] VA New York Harbor Healthcare Syst, Res Serv 151, ACOS Res & Dev, New York, NY 11209 USA
关键词
CHRONIC KIDNEY-DISEASE; HEMODIALYSIS; EPOETIN; TRIAL; ALPHA;
D O I
10.1053/j.ajkd.2012.12.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:191 / 193
页数:3
相关论文
共 8 条
[1]  
[Anonymous], 2011, FDA DRUG SAF COMM MO
[2]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[3]   Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial [J].
Gouva, C ;
Nikolopoulos, P ;
Ioannidis, JPA ;
Siamopoulos, KC .
KIDNEY INTERNATIONAL, 2004, 66 (02) :753-760
[4]   A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease [J].
Pfeffer, Marc A. ;
Burdmann, Emmanuel A. ;
Chen, Chao-Yin ;
Cooper, Mark E. ;
de Zeeuw, Dick ;
Eckardt, Kai-Uwe ;
Feyzi, Jan M. ;
Ivanovich, Peter ;
Kewalramani, Reshma ;
Levey, Andrew S. ;
Lewis, Eldrin F. ;
McGill, Janet B. ;
McMurray, John J. V. ;
Parfrey, Patrick ;
Parving, Hans-Henrik ;
Remuzzi, Giuseppe ;
Singh, Ajay K. ;
Solomon, Scott D. ;
Toto, Robert .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) :2019-2032
[5]   Facility-Level Interpatient Hemoglobin Variability in Hemodialysis Centers Participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations With Mortality, Patient Characteristics, and Facility Practices [J].
Pisoni, Ronald L. ;
Bragg-Gresham, Jennifer L. ;
Fuller, Douglas S. ;
Morgenstern, Hal ;
Canaud, Bernard ;
Locatelli, Francesco ;
Li, Yun ;
Gillespie, Brenda ;
Wolfe, Robert A. ;
Port, Friedrich K. ;
Robinson, Bruce M. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (02) :266-275
[6]   Neocytolysis contributes to the anemia of renal disease [J].
Rice, L ;
Alfrey, CP ;
Driscoll, T ;
Whitley, CE ;
Hachey, DL ;
Suki, W .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (01) :59-62
[7]   Correction of anemia with epoetin alfa in chronic kidney disease [J].
Singh, Ajay K. ;
Szczech, Lynda ;
Tang, Kezhen L. ;
Barnhart, Huiman ;
Sapp, Shelly ;
Wolfson, Marsha ;
Reddan, Donal .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2085-2098
[8]   Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm [J].
Skali, Hicham ;
Lin, Julie ;
Pfeffer, Marc A. ;
Chen, Chao-Yin ;
Cooper, Mark E. ;
McMurray, John J. V. ;
Nissenson, Allen R. ;
Remuzzi, Giuseppe ;
Rossert, Jerome ;
Parfrey, Patrick S. ;
Scott-Douglas, Nairne W. ;
Singh, Ajay K. ;
Toto, Robert ;
Uno, Hajime ;
Ivanovich, Peter .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (02) :238-246